SEGRO heads into its July 30 interim results with a striking disconnect — the lending market shows almost no bearish conviction, yet the analyst consensus has settled into a cautious hold and the stock has drifted 1% lower on the week.
The positioning story is as unambiguous as it gets. Availability in the lending pool is essentially unlimited — over 1.3 billion shares remain available to borrow, and barely any of them have been touched. The borrow rate has held in a tight range around 0.55–0.56% all month, drifting fractionally lower over the past week. The ORTEX short score of 25.3 ranks in the 99th percentile for low short-seller conviction — this is one of the least-shorted names in the market. Nothing in the lending data suggests bears are building positions ahead of the event. Cost to borrow has actually eased about 10% over the past month, which reinforces the picture: demand for shorts is fading, not growing.
What's more interesting is where the Street sits. The analyst consensus is a firm hold, with five analysts lined up there and none on outperform. The mean price target of £8.41 implies roughly 13% upside from the current close of £7.42, which is a meaningful gap — but the absence of any recent analyst target changes suggests the Street is in a wait-and-see mode rather than actively rerating the stock. The EV/EBITDA multiple has edged down about 0.14 points over the past month to 22.0x, and the P/E has drifted to 18.8x with a marginal lift over the same period. Neither move is dramatic. The analyst recommendation divergence factor score sits at 94th percentile — an unusually wide gap between where analysts have targets and where the stock is trading, which could reflect lingering caution on UK rate sensitivity rather than genuine fundamental deterioration. The EPS surprise score is weak at the 24th percentile, so the Street hasn't been consistently surprised to the upside.
Institutional ownership tells a more constructive story. The register is anchored by large, stable holders. BlackRock holds 9.8% and added roughly 918,000 shares in its most recent reported period. T. Rowe Price added 1.4 million shares, Legal & General added close to 2 million, and Artemis — a notably active UK-focused manager — put on over 3 million shares to reach a 2.2% position. Amundi and Columbia Management both added meaningfully too. Against that, ABP pension trimmed lightly. The net direction of institutional flow is clearly additive, even as the stock has underperformed its European peers — MONT fell 2.6% on the week and LMP slipped 1.5%, making SGRO's 1% decline look relatively contained. BBOX, its closest LSE peer, matched almost exactly at -1.0%.
On the insider front, the activity is largely mechanical. CEO David Sleath received share awards in March and April and sold a portion of those shares at prices between £6.39 and £6.97, consistent with a standard tax-related disposal pattern rather than directional conviction. An independent director made a small open-market purchase of roughly £33,000 in late March at £6.41 — modest in absolute terms but notable as the only discretionary buy on the register in recent months. The 90-day net insider position is slightly positive in share terms, though the value is overwhelmed by the award-related sell activity.
The July 30 print is where the price action will be tested. SEGRO's February full-year results delivered a +2.2% gain on the day and extended to +5.4% over the following week — a clean positive reaction. The April trading update pulled back 1% on the day and lost a further point over five days, a muted negative response. The pattern suggests the market responds meaningfully to full financial disclosures, less so to trading statements. With the stock up 3.8% over the past month but still well below the analyst consensus target, the question heading into July 30 is whether leasing volumes and portfolio valuation hold firm enough to close that gap — or whether rate-driven cap rate pressure gives the bears a reason to finally show up.
See the live data behind this article on ORTEX.
Open SGRO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
